What are examples of Electrochemiluminescence Immunoassay (ECLIA) and Chemiluminescent Immunoassay (CLIA) for measuring free Thyroxine (fT4) and free Triiodothyronine (fT3)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Examples of ECLIA and CLIA for Measuring Free Thyroxine (fT4) and Free Triiodothyronine (fT3)

Electrochemiluminescence Immunoassay (ECLIA) and Chemiluminescent Immunoassay (CLIA) are preferred methods for measuring free thyroid hormones due to their accuracy and reduced interference from autoantibodies compared to older radioimmunoassay techniques.

Comparison of ECLIA and CLIA Methods

ECLIA (Electrochemiluminescence Immunoassay)

  • Specific Examples:
    • Roche Modular E platform for fT4 and fT3 measurements 1, 2
    • Roche "new generation" fT4 assay (though still susceptible to antiruthenium antibody interference) 2

CLIA (Chemiluminescent Immunoassay)

  • Specific Examples:
    • Various automated direct one-step or two-step immunoassays using high molecular weight ligands or labeled antibodies 3
    • Multiple commercial platforms from different manufacturers (specific brand names not mentioned in the evidence)

Performance Characteristics

Advantages of ECLIA over Traditional Methods

  • ECLIA provides more accurate measurements in patients with triiodothyronine-binding autoantibodies compared to radioimmunoassay (RIA) 1
  • In a study of patients with T3-binding autoantibodies, ECLIA measurements of fT3 produced values that correctly reflected the patients' thyroid status, while RIA showed spuriously high results 1

Limitations and Interferences

  • Antiruthenium antibodies can cause interference in Roche ECLIA assays for TSH, fT4, and fT3 2
  • Even the newer generation Roche fT4 assay still shows interference from antiruthenium antibodies 2

Clinical Applications

Diagnostic Utility

  • Free hormone measurements (fT4 and fT3) have superseded total hormone determinations due to their higher diagnostic performance 3
  • fT4 and fT3 measurements are particularly valuable when:
    • Thyroid status is unstable (first months of treatment, altered L-T4 dose, subacute thyroiditis)
    • Hypothalamic-pituitary function is disturbed (central hypothyroidism)
    • TSH determination alone would be misleading 3

Monitoring Considerations

  • For central hypothyroidism, the Endocrine Society recommends monitoring free T4 rather than TSH, targeting the upper half of the normal range 4
  • When monitoring thyroid replacement therapy, free T4 levels should be used for patients with central hypothyroidism 4

Quality and Standardization Issues

Accuracy and Precision

  • In a comparative study by the IFCC Working Group:
    • For fT4: Only 2 of 15 immunoassays showed mean bias within 10% of the reference method
    • For fT3: Only 4 of 13 immunoassays showed mean bias within 10% of the reference method
    • Most assays showed negative biases up to -42% for fT4 and -30% for fT3 5
    • Within-run imprecision ranged from 1.0% to 11.1% for fT4 and 1.8% to 9.4% for fT3 5

Reference Methods

  • Equilibrium dialysis-isotope dilution-mass spectrometry (ED-ID-MS) is considered a reference method for free hormone measurements 5
  • Direct equilibrium dialysis/RIA can be used for simultaneous measurement of fT4 and fT3 in undiluted serum 6

Clinical Pearls

  • When interpreting thyroid function tests, it's essential to measure both TSH and free T4 simultaneously for accurate diagnosis 4
  • In patients with suspected central hypothyroidism, free T4 measurement is more reliable than TSH 3
  • When evaluating patients with non-thyroidal illness (NTI), be aware that while total T3 may be low, free T3 is often normal in approximately 83% of these patients 6

Remember that the choice between ECLIA and CLIA methods should consider potential interferences, particularly in patients with known autoantibodies to thyroid hormones.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.